These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11591203)

  • 21. Performance of two rapid, single-use immunoassays for the detection of Clostridium difficile toxin A.
    Patel JB; Donahue AM; Nachamkin I
    Diagn Microbiol Infect Dis; 2001 Jan; 39(1):21-4. PubMed ID: 11173187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of vidas Clostridium difficile toxin-A assay and premier C. difficile toxin-A assay to cytotoxin-B tissue culture assay for the detection of toxins of C. difficile.
    Knapp CC; Sandin RL; Hall GS; Ludwig MD; Rutherford I; Washington JA
    Diagn Microbiol Infect Dis; 1993 Jul; 17(1):7-12. PubMed ID: 8359010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laboratory diagnosis of clostridium difficile infection. An evaluation of tests for faecal toxin, glutamate dehydrogenase, lactoferrin and toxigenic culture in the diagnostic laboratory.
    Wren MW; Sivapalan M; Kinson R; Shetty NR
    Br J Biomed Sci; 2009; 66(1):1-5. PubMed ID: 19348118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance of TechLab C. DIFF QUIK CHEK and TechLab C. DIFFICILE TOX A/B II for the detection of Clostridium difficile in stool samples.
    Reyes RC; John MA; Ayotte DL; Covacich A; Milburn S; Hussain Z
    Diagn Microbiol Infect Dis; 2007 Sep; 59(1):33-7. PubMed ID: 17662566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the ToxA test with cytotoxicity assay and culture for the detection of Clostridium difficile-associated diarrhoea disease.
    Schué V; Green GA; Monteil H
    J Med Microbiol; 1994 Nov; 41(5):316-8. PubMed ID: 7966202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].
    Deniz U; Ulger N; Aksu B; Karavuş M; Söyletir G
    Mikrobiyol Bul; 2011 Jan; 45(1):1-10. PubMed ID: 21341153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laboratory comparison between cell cytotoxicity neutralization assay and ultrasensitive single molecule counting technology for detection of Clostridioides difficile toxins A and B, PCR, enzyme immunoassays, and multistep algorithms.
    Sandlund J; Mills R; Griego-Fullbright C; Wagner A; Estis J; Bartolome A; Almazan A; Tam S; Biscocho S; Abusali S; Nolan N; Bishop JJ; Todd J; Young S
    Diagn Microbiol Infect Dis; 2019 Sep; 95(1):20-24. PubMed ID: 31129008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low sensitivity of fecal toxin A/B enzyme immunoassay for diagnosis of Clostridium difficile infection in immunocompromised patients.
    Erb S; Frei R; Strandén AM; Dangel M; Tschudin-Sutter S; Widmer AF
    Clin Microbiol Infect; 2015 Nov; 21(11):998.e9-998.e15. PubMed ID: 26232535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Experience with laboratory diagnosis of Clostridium difficile].
    Bareková L; Zálabská E; Hanovcová I
    Klin Mikrobiol Infekc Lek; 2013 Sep; 19(3):91-5. PubMed ID: 24579451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of four methods in the diagnosis of Clostridium difficile disease.
    Mattia AR; Doern GV; Clark J; Holden J; Wu L; Ferraro MJ
    Eur J Clin Microbiol Infect Dis; 1993 Nov; 12(11):882-6. PubMed ID: 8112366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of two enzyme immunoassays for detection of Clostridium difficile toxins A and B in swine.
    Anderson MA; Songer JG
    Vet Microbiol; 2008 Apr; 128(1-2):204-6. PubMed ID: 18006252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clostridium difficile PCR Cycle Threshold Predicts Free Toxin.
    Senchyna F; Gaur RL; Gombar S; Truong CY; Schroeder LF; Banaei N
    J Clin Microbiol; 2017 Sep; 55(9):2651-2660. PubMed ID: 28615471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of different methods for detection of Clostridium difficile toxins in Poland.
    Martirosian G; Pituch H; Obuch-Woszczatyński P; Rouyan G; Meisel-Mikołajczyk F
    Acta Microbiol Pol; 1999; 48(4):349-53. PubMed ID: 10756719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of toxigenic Clostridium difficile polymerase chain reaction testing on the clinical microbiology laboratory and inpatient epidemiology.
    Napierala M; Munson E; Skonieczny P; Rodriguez S; Riederer N; Land G; Luzinski M; Block D; Hryciuk JE
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):534-8. PubMed ID: 23731555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The use of two-stage algorithm in the diagnosis of patients with low levels of Clostridium difficile toxins A/B in feces confirmed by using enzyme immunoassay].
    Nurzyńska G; Pituch H; Kamola R; Kopeć ES
    Med Dosw Mikrobiol; 2013; 65(4):263-8. PubMed ID: 24730214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in the use of laboratory tests for the diagnosis of Clostridium difficile infection and association with incidence rates in Quebec, Canada, 2010-2014.
    Bogaty C; Lévesque S; Garenc C; Frenette C; Bolduc D; Galarneau LA; Lalancette C; Loo V; Tremblay C; Trudeau M; Vachon J; Dionne M; Villeneuve J; Longtin J; Longtin Y;
    Am J Infect Control; 2017 Sep; 45(9):964-968. PubMed ID: 28549882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Considerations in the laboratory diagnosis of antibiotic-associated gastroenteritis.
    Ryan RW
    Diagn Microbiol Infect Dis; 1986 Mar; 4(3 Suppl):79S-86S. PubMed ID: 3516548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Importance of culture for detection of Clostridium difficile toxin from stool samples to report true incidence and mortality related to C. difficile in hospitals.
    Bayardelle P
    Clin Infect Dis; 2009 Oct; 49(7):1134-5; author reply 1135. PubMed ID: 19739961
    [No Abstract]   [Full Text] [Related]  

  • 39. Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (Toxin A), and tcdB (Toxin B) genes for toxigenic culture of Clostridium difficile.
    Lemee L; Dhalluin A; Testelin S; Mattrat MA; Maillard K; Lemeland JF; Pons JL
    J Clin Microbiol; 2004 Dec; 42(12):5710-4. PubMed ID: 15583303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of three commercial methods for rapid detection of Clostridium difficile toxins A and B from fecal specimens.
    Alcalá L; Sánchez-Cambronero L; Catalán MP; Sánchez-Somolinos M; Peláez MT; Marín M; Bouza E
    J Clin Microbiol; 2008 Nov; 46(11):3833-5. PubMed ID: 18784313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.